THE TRANSFUSION EFFECT IN CADAVER KIDNEY-TRANSPLANTS - YES OR NO

被引:41
作者
IWAKI, Y
CECKA, JM
TERASAKI, PI
机构
[1] The Tissue Typing Laboratory, Department of Surgery, UCLA School of Medicine, Los Angeles, CA
关键词
D O I
10.1097/00007890-199001000-00012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The transfusion effect in first cadaver kidney transplants was re-examined at the UCLA Transplant Registry. One-year graft survival rates were 71% for nontransfused patients, which improved to 75% (P<0.05) with a single transfusion, 77% (P<0.01) with 2 and 78% (P<0.01) with 3 and 4 transfusions. One-year graft survival rates did not improve further with additional transfusions but remained at the same level. Thus, the transfusion effect clearly does exist, and 2 to 4 transfusions are sufficient to obtain the maximum beneficial transfusion effect. Patients with zero HLA-DH mismatched transplants had no blood transfusion effect. Transfusions improved the 1-year graft survival rate by 8% for transplant recipients with 1 DR-mismatched grafts (P<0.01) and by 10% with 2 DR-mismatched grafts (P<0.01). The transfusion effect was greater in Black than White recipients; however, the 77% 1-year graft survival rate for transfused Black recipients of zero DR-mismatched kidneys did not differ from thatof transfused omparably matched Whites. We conclude that transfusion protocols should not be abandoned unless patients receive zero DR-mismatched kidneys. © 1990 by Williams and Wilkins.
引用
收藏
页码:56 / 59
页数:4
相关论文
共 15 条
  • [1] Cecka J M, 1987, Clin Transpl, P287
  • [2] BLOOD-TRANSFUSIONS AND HLA MATCHING - AN EITHER OR SITUATION IN CADAVERIC RENAL-TRANSPLANTATION
    CECKA, JM
    CICCIARELLI, J
    MICKEY, MR
    TERASAKI, PI
    [J]. TRANSPLANTATION, 1988, 45 (01) : 81 - 86
  • [3] CECKA M, 1985, CLIN KIDNEY TRANSPLA, P73
  • [4] IWAKI Y, 1988, CLIN TRANSPLANT 198, V283, P292
  • [5] KAHAN BD, 1983, TRANSPLANT P, V15, P2469
  • [6] Lagaaij E L, 1987, Clin Transpl, P243
  • [7] Lundgren G, 1987, Clin Transpl, P249
  • [8] LUNDGREN G, 1986, LANCET, V2, P66
  • [9] NAKATA S, 1980, HISTOCOMPATIBILITY T, P590
  • [10] Opelz G, 1987, Clin Transpl, P239